Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
Korea University Guro Hospital
University of Miami
Norwegian University of Science and Technology
Washington University School of Medicine
Albany Medical College
Cairo University
University of Rochester
Ankara University
St. Joseph's Hospital and Medical Center, Phoenix
Kyunghee University Medical Center
University of Rochester
Vanderbilt-Ingram Cancer Center
University of Southern California
Milton S. Hershey Medical Center
University of California, Los Angeles
University of Copenhagen
M.D. Anderson Cancer Center
Samsung Medical Center
Samsung Medical Center
NHS Greater Glasgow and Clyde
Nova Scotia Health Authority